Pazopanib in Combination With Capecitabine in Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Pazopanib plus capecitabine
Sponsor: German Breast Group